Cyclacel Pharmaceuticals Cash from Financing (TTM) Trends

Cyclacel Pharmaceuticals Inc (CYCC)

2.27 -0.04 (-1.73%) USD | NASDAQ | May 10, 16:00

2.27 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2003. Upgrade now.

Date	Value
December 31, 2023	0.848M
September 30, 2023	-0.109M
June 30, 2023	1.473M
March 31, 2023	2.998M
December 31, 2022	2.998M
September 30, 2022	3.843M
June 30, 2022	5.215M
March 31, 2022	3.69M
December 31, 2021	21.74M
September 30, 2021	32.20M
June 30, 2021	29.24M
March 31, 2021	47.55M
December 31, 2020	29.50M
September 30, 2020	18.11M
June 30, 2020	18.10M
March 31, 2020	-0.258M
December 31, 2019	3.848M
September 30, 2019	4.478M
June 30, 2019	4.485M
March 31, 2019	4.535M
December 31, 2018	0.429M
September 30, 2018	-0.003M
June 30, 2018	13.68M
March 31, 2018	14.66M
December 31, 2017	14.75M

Date	Value
September 30, 2017	16.10M
June 30, 2017	7.502M
March 31, 2017	6.68M
December 31, 2016	6.594M
September 30, 2016	5.525M
June 30, 2016	0.658M
March 31, 2016	0.427M
December 31, 2015	10.86M
September 30, 2015	11.81M
June 30, 2015	11.59M
March 31, 2015	20.96M
December 31, 2014	12.20M
September 30, 2014	12.77M
June 30, 2014	15.89M
March 31, 2014	25.67M
December 31, 2013	27.33M
September 30, 2013	26.42M
June 30, 2013	23.36M
March 31, 2013	4.315M
December 31, 2012	3.975M
September 30, 2012	2.943M
June 30, 2012	12.27M
March 31, 2012	12.11M
December 31, 2011	8.906M
September 30, 2011	23.01M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.258M

Minimum

Mar 2020

47.55M

Maximum

Mar 2021

12.10M

Average

4.478M

Median

Sep 2019

Cash from Financing (TTM) Benchmarks